JPMorgan Chase & Co. Reiterates “€48.70” Price Target for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Fresenius Medical Care AG & Co. KGaA (ETR:FMEGet Rating) received a €48.70 ($51.26) price target from investment analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Wednesday, Borsen Zeitung reports. JPMorgan Chase & Co.‘s target price suggests a potential downside of 19.37% from the company’s previous close.

Several other equities analysts have also issued reports on the company. Barclays set a €68.00 ($71.58) price target on Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, April 26th. Jefferies Financial Group set a €53.00 ($55.79) target price on shares of Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, February 22nd. Deutsche Bank Aktiengesellschaft set a €58.00 ($61.05) price target on shares of Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, March 22nd. Berenberg Bank set a €83.40 ($87.79) price objective on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, April 29th. Finally, Kepler Capital Markets set a €59.00 ($62.11) target price on Fresenius Medical Care AG & Co. KGaA in a research note on Monday, January 10th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of €65.47 ($68.91).

FME stock opened at €60.40 ($63.58) on Wednesday. The business has a 50 day moving average of €59.66 and a 200 day moving average of €58.58. The firm has a market cap of $17.70 billion and a PE ratio of 18.25. Fresenius Medical Care AG & Co. KGaA has a twelve month low of €50.98 ($53.66) and a twelve month high of €71.14 ($74.88). The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 95.29.

Fresenius Medical Care AG & Co. KGaA Company Profile (Get Rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Stories

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.